Blog posts written by: Szonja Skenderovic

Thursday, 6th June, 2024
Ambition for change: Building a healthier and happier world

Sam Feltham, the Director of Public Health Collaboration (PHC), UK, started his workshop with the brave statement, ´Achieving metabolic health is the key to longevity.´ Worryingly, the statistics that he presented that life expectancy is actually stalling, and the number of people living with major health conditions, such as diabetes, is increasing. In the UK 25% of adults are obese and cases of type 2 diabetes have risen by around 65% in the past 10 years, with no sign of slowing down. These conditions cost the NHS approximately £16 billion a year. Furthermore, the NHS lacks capacity and has severe staff shortages. Doctors are experiencing high levels of stress and burnout, making it difficult to properly address these conditions for all patients.

However, all is not lost! This is where PHC comes in, with a goal to support weight loss journeys for individuals with diabetes. Sam believes that to improve the health of the nation, a complete overhaul is needed with regards to dietary advice based on scientific evidence. According to Public Health England (PHE), our total food consumption is on average, 394 calories below the recommended calorie intake per day, our total fat consumption is below the recommended 35% that is recommended, and we’re four grams under the recommended amount of daily red meat intake. PHC works to improve healthy eating guidelines and to reverse the deterioration of public heath. Their approach, The Real Food Lifestyle, consists of naturally nutrient-dense foods that are minimally altered from their natural state while avoiding starchy carbohydrates, rather than avoiding fats.

Currently, the majority of nutrition science is based on observational data and epidemiology. Randomized controlled trials (RCTs) are the gold standard for practicing evidence-based nutrition and therefore PHC reviewed and analysed a number of RCTs to back up their claims. In their summary table, the evidence is clear – reducing overall carbohydrate intake for individuals with diabetes supports weight loss and either improves glycemic control and insulin resistance or reduces the need for anti-hyperglycemic therapies.

Sam wants to get everyone to focus on good metabolic health by distributing these findings through the projects that PHC offers, most notably The Lifestyle Club (TLC). However, PHC also has other projects for different demographics and for achieving different types of goals. TLC is PHC’s award-winning online health coaching service, which the NHS commissions, helping people with type 2 diabetes and prediabetes to improve their lifestyles. The approach is simple reduce the amount of ingested sugar and starchy carbohydrates, to eat ‘Real Foods’, and to stay hydrated. Comparing TLC to other common diabetes lifestyle programmes, such as the NHS Diabetes Prevention Programme (NDPP) and NHS DESMOND, TLC has demonstrated an impressive improvement in patient results, with a close to double weight loss rate. TLC not only a cheaper alternative, but also tackles both prediabetes and diabetes with greater efficiency. The project has achieved strong patient engagement and has a strong community of participants that offer peer support.

What is the end goal of PHC? It is to build a society in which everyone enjoys good metabolic health and to this aim, to reverse the type 2 diabetes and prediabetes epidemic in the UK and undo the childhood obesity crisis through high-quality research projects and collaborations with universities.

 

Friday, 7th June, 2024
Genesis: The origins of your gut microbiota
Dr Sheena Fraser, Dr Siobhan McCormack, British Society of Lifestyle Medicine

In the last couple of years, there has been a steadily growing interest in the human microbiome, with numerous publications on the topic. Dr Sheena Fraser and Dr Siobhan McCormack, the founders of Microbiome Medics, are only two practitioners out of the many, who have started to spread awareness about the importance of the microbiome.They dedicated their workshop at the conference to discussing early life microbiome development.

The microbiome is comprised of the microbiota (consisting of microorganisms such as bacteria, fungi, viruses) that naturally live on and inside our bodies. By cell count, humans are in fact, 50% microbial! Each person’s microbiome is unique, acting like a biological fingerprint that can even be used in forensic science. This uniqueness is not just a curiosity. It holds the key to understanding why individuals respond differently to the same drugs and how we can better manage chronic diseases. The Microbiome Medics gave several examples of how these differences can indicate a higher risk of developing certain diseases and that they can be detected from birth.

The health of a mother significantly influences the composition of her child’s initial microbiota and so does the mode of delivery. During a vaginal birth, babies are exposed to and acquire part of the mother’s vaginal and gut microbiota, which are vital for seeding the infant’s microbiome. This natural exposure to a healthy microbiome provides immediate benefits such as a lower risk of obesity and diabetes later in life. Conversely, babies delivered via Caesarean section (C-section) miss out on this microbial exposure. Instead, infants delivered by C-section harbor microbiota similar to those found on the surface of maternal skin and in the operating room. Studies have shown that C-section-delivered infants have a less diverse microbiome and are at a higher risk for developing chronic conditions such as neurodevelopmental disorders and metabolic and autoimmune diseases. The disparity in microbial exposure during birth emphasizes the importance of promoting vaginal deliveries whenever possible and finding ways to restore the gut microbiota to deliver health benefits to infants delivered by C-section.

Microbiome Medics also discussed other ways in which mothers can impact the healthy development of their child’s microbiota such as by breastfeeding. Despite human milk oligosaccharides (HMOs) being the third-largest component in breastmilk, they are indigestible by infants. However, these molecules serve as prebiotics that nourish beneficial gut bacteria. This suggests that breast milk is designed to aid the development of the infant microbiome! HMOs support the growth of a diverse microbiota that are essential for the development of the immune system and protecting against pathogens. In contrast, formula-fed infants may not receive the same microbial benefits, in part due to the lack of HMOs in infant formula milk.

The differences in microbiome development based on birth method and breastfeeding have enormous implications for a person´s health. However, as stated by the Microbiome Medics, cultural norms heavily impact the choices that a mother makes when it comes to the mode of delivery. For example, around 25% of deliveries happen by C-section in the UK, while in Brazil, that number soarsto 56%. Open, candid conversations about birth and support from practitioners could encourage more mothers to choose vaginal delivery, if this is a feasible option for them.

Several novel methods for reversing microbiome disturbances caused by C-section and formula-feeding are being investigated. For example, for infants born via C-section, vaginal microbiota transfer by exposure to maternal vaginal fluids is currently being studied. For formula-fed infants, the current solution is supplementation of infant formula with commercially available HMOs. These processes of ´microbiome modulation´ in babies, may lead to new methods of preventing disease in later life.

Saturday, 8th June 2024
Rayonex medical study on chronic pain relief and the automatic Rayoscan

Thomas Warrior, CEO and International Trainer, Rayonex Biomedical UK

Thomas Warrior, CEO of Rayonex Biomedical gave a thought-provoking presentation about bioresonance as a health practice. His workshop delved into the science and scrutiny behind bioresonance, and the application of Rayonex´s first devices, Rayocomp and Rayonex-Mini.

Bioresonance is based on the principle that as matter has a resonant frequency so do the cells in our bodies. An example of bioresonance is our skin’s reaction to the sun when hit by the frequency spectrum of UV light, it darkens. This simple concept explored by Paul Schmidt, led to the discovery of how other frequency spectra affect our bodies. Bioresonance according to Paul Schmidt (BaPS), stimulates the organism to support self-regulation. Rayonex’s medical application of BaPS includes approved medical devices of Class I and Class IIA, positioning Rayonex Biomedical as one of the leading giants in the bioresonance sphere.

Rayonex Biomedical has been at the forefront of bioresonance research, conducting several studies on BaPS and heart rate variability. They are the first company that received a gold standard study for their new clinical prospective, double-blind, randomized study on pain reduction in patients with cervical spine syndrome. This high level of accreditation demonstrates that the experimental model has been thoroughly tested and has a reputation in the field as a reliable method. The study showed significant improvements in all symptoms for patients treated with the Rayocomp bioresonance device, compared to a placebo group. Those who received the placebo treatment continued to experience the typical symptoms of cervical spine syndrome such as neck pain, headaches, back pain and, muscle tension.

Thomas Warrior announced the success of the Mini-Rayonex, Rayonex´s first device on Amazon.de, which became top-rated in its category and is set to launch on the UK website in the near future. This hand-held device fights the ill effects of electromagnetic radiation and is user-friendly, with no learning curve. Its applications range from addressing allergies and vaccine side effects to improving sleep disorders.

However, despite the promising results Rayonex has shown, bioresonance therapy faces a high degree of scepticism within the medical community. Rayonex stands out as the only bioresonance device manufacturer to have achieved certification for medical production, reflecting the rigorous standards required. Breaking into the medical field remains a significant challenge for bioresonance device manufacturers due to skepticism, high prices and the stringent requirements for acceptance. Thomas used the last few minutes of his talk to emphasize his commitment to combating the negative bias that bioresonance faces within the medical community.

BaPS, as presented by Thomas Warrior, offers a new horizon in chronic pain relief and holistic health management. Rayonex Biomedical’s case studies and researches have paved the way for significant advancements in this field. Clear and statistically significant evidence of the benefits of this technology from further clinical trials will be needed before there can be a broader acceptance of it within the medical community.

 

Leave a Reply

Your email address will not be published. Required fields are marked *